PCVX
Price
$37.05
Change
+$0.84 (+2.32%)
Updated
Jul 21, 10:38 AM (EDT)
Capitalization
4.67B
22 days until earnings call
RLFTF
Price
$2.75
Change
-$0.10 (-3.51%)
Updated
Jul 18 closing price
Capitalization
34.77M
Interact to see
Advertisement

PCVX vs RLFTF

Header iconPCVX vs RLFTF Comparison
Open Charts PCVX vs RLFTFBanner chart's image
Vaxcyte
Price$37.05
Change+$0.84 (+2.32%)
Volume$1.3K
Capitalization4.67B
RELIEF THERAPEUTICS HLDG AG
Price$2.75
Change-$0.10 (-3.51%)
Volume$1.01K
Capitalization34.77M
PCVX vs RLFTF Comparison Chart in %
Loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLFTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCVX vs. RLFTF commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a Hold and RLFTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (PCVX: $36.21 vs. RLFTF: $2.75)
Brand notoriety: PCVX and RLFTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 71% vs. RLFTF: 23%
Market capitalization -- PCVX: $4.67B vs. RLFTF: $34.77M
PCVX [@Biotechnology] is valued at $4.67B. RLFTF’s [@Biotechnology] market capitalization is $34.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green whileRLFTF’s FA Score has 1 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • RLFTF’s FA Score: 1 green, 4 red.
According to our system of comparison, PCVX is a better buy in the long-term than RLFTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 5 TA indicator(s) are bullish while RLFTF’s TA Score has 2 bullish TA indicator(s).

  • PCVX’s TA Score: 5 bullish, 4 bearish.
  • RLFTF’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than RLFTF.

Price Growth

PCVX (@Biotechnology) experienced а +0.78% price change this week, while RLFTF (@Biotechnology) price change was -4.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

PCVX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.67B) has a higher market cap than RLFTF($34.8M). RLFTF YTD gains are higher at: -40.980 vs. PCVX (-55.766).
PCVXRLFTFPCVX / RLFTF
Capitalization4.67B34.8M13,422%
EBITDA-512.62MN/A-
Gain YTD-55.766-40.980136%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash1.67BN/A-
Total Debt87.2MN/A-
TECHNICAL ANALYSIS
Technical Analysis
PCVXRLFTF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
71%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 11 days ago
67%
Declines
ODDS (%)
Bearish Trend 15 days ago
80%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
76%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLFTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIEAX42.820.09
+0.21%
BNY Mellon International Core Equity A
MUOSX32.000.05
+0.16%
Morgan Stanley Instl US Core R6
GSEPX69.170.04
+0.06%
Goldman Sachs US Equity Insights P
CMLAX59.87-0.03
-0.05%
American Funds American Mutual 529A
JSEQX54.05-0.25
-0.46%
JPMorgan Small Cap Equity R4

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with DNLI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-0.98%
DNLI - PCVX
44%
Loosely correlated
-3.65%
ORKA - PCVX
44%
Loosely correlated
-5.34%
KYMR - PCVX
40%
Loosely correlated
-0.37%
DYN - PCVX
40%
Loosely correlated
-4.04%
TSHA - PCVX
40%
Loosely correlated
-0.77%
More

RLFTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTF has been loosely correlated with RLFTY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTF jumps, then RLFTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTF
1D Price
Change %
RLFTF100%
-3.60%
RLFTY - RLFTF
46%
Loosely correlated
N/A
ORKA - RLFTF
32%
Poorly correlated
-5.34%
GNTA - RLFTF
24%
Poorly correlated
-0.26%
PCVX - RLFTF
21%
Poorly correlated
-0.98%
ONTTF - RLFTF
20%
Poorly correlated
-2.94%
More